Nur für Premium Nutzer:
Jetzt 14 Tage kostenfrei testen
| Beispiel PDF herunterladen
Noch 3 von 3 Checks heute möglich
Mit dem Seobility Widget kannst Du Besuchern Deiner Website zeigen, wie gut Deine Seite SEO-optimiert ist. Das Widget zeigt immer den aktuellen SEO-Score Deiner Homepage/Startseite an.
Name | Wert |
---|---|
viewport | width=device-width, initial-scale=1.0 |
robots | index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1 |
description | Onco'Zine is part of the Oncology and Hematology News Network that has been created to better inform physicians treating patients with cancer |
msvalidate.01 | 325DBF0B4415B7D5F77949B32086EEB2 |
google-site-verification | DvS50_-wX_jjHKRtegP7b3R6lPTOcwGV7N7mm1J2oAk |
generator | WordPress 6.5.5 |
msapplication-TileImage | https://www.oncozine.com/wp-content/uploads/2018/09/cropped-circle-270x270.png |
article:publisher | https://www.facebook.com/oncozine.journal |
article:modified_time | 2023-11-14T01:28:40+00:00 |
lang | en-us |
twitter:card | summary_large_image |
twitter:site | @OncoZine |
fb:pages | https://www.facebook.com/OncoZine/ |
og:locale | en_US |
og:type | website |
og:title | Home - Onco'Zine - A part of the Oncology and Hematology News Network |
og:description | Onco'Zine is part of the Oncology and Hematology News Network that has been created to better inform physicians treating patients with cancer |
og:url | https://www.oncozine.com/ |
og:site_name | Onco'Zine |
charset | UTF-8 |
URL | ALT-Attribute | Titel |
---|---|---|
...tent/uploads/2019/06/oncozine_270x90.png | OncoZine, The International On | OncoZine, The International Oncology Network |
.../uploads/2019/06/oncozine-140x48_wht.png | OncoZine, The International On | OncoZine, The International Oncology Network |
...tent/uploads/2019/06/oncozine_270x90.png | OncoZine, The International On | OncoZine, The International Oncology Network |
...ads/2020/02/oncozine_brief-300x250-1.png | spot_img | |
...F4D-4F06-AB10-E80D755FFC56_4_5005_c.jpeg | spot_img | |
...ers-of-the-Cancer-Universe-300x250-1.jpg | spot_img | |
.../uploads/2019/06/oncozine_270x90_wht.png | Onco\ | Onco\'Zine, The International Oncology Network |
...nt/uploads/2021/05/subcription-popup.png | Kein ALT-Attribut angegeben |
Überschriften Hierarchie | Inhalt |
---|---|
H1 | Onco'Zine OncoZine, The International Oncology Network |
H3 | Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials |
H3 | Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show |
H3 | Study Shows New Co-Star Receptor to be Promising in Cancer Treatment |
H3 | The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many |
H3 | ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011 |
H3 | Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials Text-Duplikat |
H3 | Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show Text-Duplikat |
H3 | The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many Text-Duplikat |
H3 | The Transformative Potential of Exosome Research in Cancer Detection and Beyond |
H3 | A Global View of Oncology Informatics |
H3 | Standardizing Immunophenotyping Research Tools to Improve MDS and the Immune System |
H3 | Experts Forecast: Achieving Cancer Health Equity |
H3 | The Impact of DCISionRT Versus Clinicopathologic Factors Alone in Predicting Benefit of Radiation |
H3 | Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials Text-Duplikat |
H3 | Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show Text-Duplikat |
H3 | Study Shows New Co-Star Receptor to be Promising in Cancer Treatment Text-Duplikat |
H3 | The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many Text-Duplikat |
H3 | ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011 Text-Duplikat |
H3 | ASCO 2024: Adagrasib Shows Statistically Significant Improvement in PFS in KRASG12C-Mutated NSCLC |
H3 | ASCO 2024: A More Effective Treatment Combination for Hodgkin Lymphoma |
H3 | ASCO 2024: Asciminib – A Safer + More Effective Option for Newly Diagnosed Chronic... |
H3 | ASCO 2024: Durable Efficacy of Lorlatinib as a first-line choice in ALK-positive NSCLC n |
H3 | ASCO 2024: NATALEE shows Ribociclib Reduces Risk of Cancer Recurrence in Early Breast Cancer |
H3 | ASCO 2024: AbbVie to Showcases Robust Solid Tumor Pipeline with New Data from Its... |
H3 | Strong Immunology Portfolio helps Offset losses of AbbVie’s Adalimumab |
H3 | ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011 Text-Duplikat |
H3 | ASCO 2024: Adagrasib Shows Statistically Significant Improvement in PFS in KRASG12C-Mutated NSCLC Text-Duplikat |
H3 | ASCO 2024: A More Effective Treatment Combination for Hodgkin Lymphoma Text-Duplikat |
H3 | ASCO 2024: Asciminib – A Safer + More Effective Option for Newly Diagnosed Chronic... Text-Duplikat |
H3 | ASCO 2024: Durable Efficacy of Lorlatinib as a first-line choice in ALK-positive NSCLC n Text-Duplikat |
H3 | ASCO 2024: NATALEE shows Ribociclib Reduces Risk of Cancer Recurrence in Early Breast Cancer Text-Duplikat |
H3 | ASCO 2024: AbbVie to Showcases Robust Solid Tumor Pipeline with New Data from Its... Text-Duplikat |
H3 | ASCO 2024: Bristol Myers Squibb to Present Results from 130 Studies |
H3 | Encouraging Conversation & Action on Sexual Health and Fertility for Patients Diagnosed with Cancer |
H3 | Increased Overall Survival Reported for Combination of Durvalumab plus Chemotherapy |
H3 | Study Shows Positive Results in Treatment of Cervical High-Grade Squamous Intraepithelial Lesion |
H3 | Immunotherapy After Surgery Improves Survival in Patients with Kidney Cancer |
H3 | A Global View of Oncology Informatics Text-Duplikat |
H3 | Standardizing Immunophenotyping Research Tools to Improve MDS and the Immune System Text-Duplikat |
H3 | Experts Forecast: Achieving Cancer Health Equity Text-Duplikat |
H3 | The Impact of DCISionRT Versus Clinicopathologic Factors Alone in Predicting Benefit of Radiation Text-Duplikat |
H3 | Forecast 2024: Broadening the Reach of Cancer Vaccines |
H3 | The Digital Frontier: 5 Ways Oncology Informatics is Enhancing Cancer Care |
H3 | Remembering Emil “Jay” Freireich—the Man Who Made Vince DeVita a ‘Believer’ |
H3 | Why Were Top HHS Officials? Interviews Thwarted by Their Press Offices? |
H3 | Jason Moore, PhD: Improving the Lives of Patients through Computing Technologies and Data Resources |
H3 | SonALAsense: Developing a Safe and Effective Noninvasive Treatment for Cancer |
H3 | Be The Match®: Improving Outcomes and Providing Hope to Patients in Need |
H3 | Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials Text-Duplikat |
H3 | Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show Text-Duplikat |
H3 | Study Shows New Co-Star Receptor to be Promising in Cancer Treatment Text-Duplikat |
H3 | Daiichi Sankyo Out-Licenses Investigational Agent DS-6051 to AnHeart Therapeutics |
H3 | How Meaningful Will Changes Be to Ethical Guidelines Following Jose Baselga’s Fall? |
H3 | Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’... |
H4 | FEATURED |
H4 | NEWS |
H4 | CONFERENCE COVERAGE |
H4 | EDITORIAL |
H4 | ERIC ROSENTHAL REPORTS |
H4 | EXPERT INTERVIEWS |
Link | Attribute | Linktext |
---|---|---|
https://www.facebook.com/oncoz... | Neues Fenster Extern Subdomain | A-TITLE Facebook |
https://www.linkedin.com/showc... | Neues Fenster Extern Subdomain | A-TITLE Linkedin |
https://soundcloud.com/hofrey | Neues Fenster Extern | A-TITLE Soundcloud |
https://twitter.com/OncoZine | Neues Fenster Extern | A-TITLE Twitter |
https://vimeo.com/channels/877242 | Neues Fenster Extern | A-TITLE Vimeo |
https://www.youtube.com/channe... | Neues Fenster Extern Subdomain | A-TITLE Youtube |
https://www.xing.com/communiti... | Neues Fenster Extern Subdomain | A-TITLE Xing |
https://www.oncozine.com/ | Subdomain | Home |
/advertisement-sponsorship-opt... | Subdomain | Advertisement & Sponsorship Options |
https://lp.constantcontactpage... | Extern Subdomain | Download Our Media Kit |
/continued-medical-education-cme/ | Subdomain | Changing Physician Behavior |
/cancer-information-by-disease/ | Subdomain | Cancer A – Z |
http://www.oncozine.com/ | Subdomain | Drug Developmemt Technologies |
/a-novel-technology-based-on-s... | Subdomain | A Novel Technology based on Somatic Hypermutation (SHM) |
/about-oncozine/advisory-board-3/ | Subdomain | Editorial Advisory Board |
/join-our-editorial-advisory-b... | Subdomain | Join Our Editorial Advisory Board |
/contact-us/ | Subdomain | Contact Us |
/terms-and-conditions/ | Subdomain | Terms and Conditions |
/sabcs-and-ash-2023/ | Subdomain | SABCS and ASH 2023 |
http://www.adcreview.com/ | Extern Subdomain | ADC Review | J. Antibody-drug Conjugates |
https://www.adcreview.com/reso... | Extern Subdomain | Resources for For Clinicians |
https://www.adcreview.com/adc-... | Extern Subdomain | Drug Map (ADC) |
https://www.adcreview.com/cate... | Extern Subdomain | Peer Review Articles |
https://www.adcreview.com/the-... | Extern Subdomain | The Review |
/changing-strategies-in-the-wa... | Subdomain | Changing Strategies in the War on Cancer |
/changing-strategies-in-the-wa... | Subdomain | Changing Strategies in the War on Cancer – Episode 1 |
/changing-strategies-in-the-wa... | Subdomain | Changing Strategies in the War on Cancer – Episode 2 |
/changing-strategies-in-the-wa... | Subdomain | Changing Strategies in the War on Cancer – Episode 3 |
/centers-of-the-cancer-univers... | Subdomain | Centers of the Cancer Universe: A Half-Century of Progress Against Cancer |
http://cartcelljournal.com/ | Extern | Journal of CAR T-Cell Therapy |
http://cartcelljournal.com/about/ | Extern | About CAR T-cells |
http://cartcelljournal.com/faq/ | Extern | Frequently Asked Questions |
http://cartcelljournal.com/art... | Extern | Types of Articles |
http://cartcelljournal.com/for... | Extern | Submit a Manuscript |
/the_oncozine_brief_episodes/ | Subdomain | The Onco’Zine Brief |
/the_oncozine_brief_episodes/ | Subdomain | The Network |
/the-oncozine-brief-episodes/ | Subdomain | The Episodes |
https://www.patreon.com/theonc... | Neues Fenster Extern Subdomain | How to Support The Onco’Zine Brief |
/underwriting/ | Subdomain | Corporate Underwriting and Sponsorship |
/the-oncozine-dossier/ | Subdomain | The Onco’Zine Dossier |
/thalidomide-a-history/ | Subdomain | Thalidomide: A History |
/thalidomide-in-the-shadow-of-... | Subdomain | Thalidomide: In the Shadow of Death |
/controversy-the-involvement-o... | Subdomain | Controversy: The involvement of Ciba AG in the development of Thalidomide |
/thalidomides-secret-past-the-... | Subdomain | Thalidomide’s Secret Past: The Link with Nazi Germany |
/reversal-of-fortune-how-a-vil... | Subdomain | Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer |
/oncozine-dossier-50-years-aft... | Subdomain | Smoking and Health |
/new-surgeon-generals-report-p... | Subdomain | New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco |
/smoking-and-the-lost-legacy-o... | Subdomain | Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health |
/tobacco-control-in-the-united... | Subdomain | Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years |
http://.com/tobacco-companies-... | Extern | Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking |
/the-harmful-effects-of-smokin... | Subdomain | The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s |
/oncozine.com/oncology-hematol... | Subdomain | Drug Approvals 2017 – 2020 |
/oncology-hematology-drug-appr... | Subdomain | Oncology & Hematology – FDA Drug Approvals 2018 |
/oncology-hematology-fda-drug-... | Subdomain | Oncology & Hematology – FDA Drug Approvals 2019 |
/oncology-hematology-fda-drug-... | Subdomain | Oncology & Hematology – FDA Drug Approvals 2020 |
/category/articles/ | Subdomain | Articles |
/category/latest-articles/ | Subdomain | Latest Articles |
/category/expert-interviews/ | Subdomain | Expert Interviews |
/category/editorial-and-commen... | Subdomain | Editorials and Commentaries |
/category/eric-rosenthal-reports/ | Subdomain | Eric Rosenthal Reports |
/category/publications-peer-re... | Subdomain | Publications |
/category/news/ | Subdomain | News |
/category/business-economics/ | Subdomain | Business & Economics |
/category/clinical-development/ | Subdomain | Clinical Development |
/category/conference-coverage/ | Subdomain | Conference Coverage |
/the_oncozine_brief_episodes/ | Subdomain Textduplikat | The Onco’Zine Brief |
/the-oncozine-brief-episodes/ | Subdomain Textduplikat | The Episodes |
/the-oncozine-brief-national-a... | Subdomain | National Advertising |
http://www.oncozine.com/ | Neues Fenster Subdomain | Resources |
https://www.oncologydirectory.... | Neues Fenster Extern Subdomain | Membership |
https://www.oncologydirectory.... | Extern Subdomain | Agenda |
https://www.oncologydirectory.... | Neues Fenster Extern Subdomain | Join Today |
https://www.oncologydirectory.... | Neues Fenster Extern Subdomain | Video |
/job-openings/ | Subdomain | Careers |
/about-oncozine/about-oncozine-2/ | Subdomain | About |
/about-oncozine/advertise-with... | Subdomain | Advertise |
/about-oncozine/advisory-board... | Subdomain | Advisory Board |
/contact-us/ | Subdomain Textduplikat | Contact Us |
https://www.facebook.com/oncoz... | Neues Fenster Extern Subdomain Textduplikat | A-TITLE Facebook |
https://www.linkedin.com/showc... | Neues Fenster Extern Subdomain Textduplikat | A-TITLE Linkedin |
https://soundcloud.com/hofrey | Neues Fenster Extern Textduplikat | A-TITLE Soundcloud |
https://twitter.com/OncoZine | Neues Fenster Extern Textduplikat | A-TITLE Twitter |
https://vimeo.com/channels/877242 | Neues Fenster Extern Textduplikat | A-TITLE Vimeo |
https://www.youtube.com/channe... | Neues Fenster Extern Subdomain Textduplikat | A-TITLE Youtube |
https://www.xing.com/communiti... | Neues Fenster Extern Subdomain Textduplikat | A-TITLE Xing |
https://www.oncozine.com/ | Subdomain | Onco'Zine IMG-ALT OncoZine, The International Oncology Network |
https://www.oncozine.com/ | Subdomain | IMG-ALT OncoZine, The International Oncology Network |
https://www.oncozine.com/ | Subdomain Textduplikat | IMG-ALT OncoZine, The International Oncology Network |
https://www.oncozine.com/ | Subdomain Textduplikat | Home |
/advertisement-sponsorship-opt... | Subdomain Textduplikat | Advertisement & Sponsorship Options |
https://lp.constantcontactpage... | Extern Subdomain Textduplikat | Download Our Media Kit |
/continued-medical-education-cme/ | Subdomain Textduplikat | Changing Physician Behavior |
/cancer-information-by-disease/ | Subdomain Textduplikat | Cancer A – Z |
http://www.oncozine.com/ | Subdomain Textduplikat | Drug Developmemt Technologies |
/a-novel-technology-based-on-s... | Subdomain Textduplikat | A Novel Technology based on Somatic Hypermutation (SHM) |
/about-oncozine/advisory-board-3/ | Subdomain Textduplikat | Editorial Advisory Board |
/join-our-editorial-advisory-b... | Subdomain Textduplikat | Join Our Editorial Advisory Board |
/contact-us/ | Subdomain Textduplikat | Contact Us |
/terms-and-conditions/ | Subdomain Textduplikat | Terms and Conditions |
/sabcs-and-ash-2023/ | Subdomain Textduplikat | SABCS and ASH 2023 |
http://www.adcreview.com/ | Extern Subdomain Textduplikat | ADC Review | J. Antibody-drug Conjugates |
https://www.adcreview.com/reso... | Extern Subdomain Textduplikat | Resources for For Clinicians |
https://www.adcreview.com/adc-... | Extern Subdomain Textduplikat | Drug Map (ADC) |
https://www.adcreview.com/cate... | Extern Subdomain Textduplikat | Peer Review Articles |
https://www.adcreview.com/the-... | Extern Subdomain Textduplikat | The Review |
/changing-strategies-in-the-wa... | Subdomain Textduplikat | Changing Strategies in the War on Cancer |
/changing-strategies-in-the-wa... | Subdomain Textduplikat | Changing Strategies in the War on Cancer – Episode 1 |
/changing-strategies-in-the-wa... | Subdomain Textduplikat | Changing Strategies in the War on Cancer – Episode 2 |
/changing-strategies-in-the-wa... | Subdomain Textduplikat | Changing Strategies in the War on Cancer – Episode 3 |
/centers-of-the-cancer-univers... | Subdomain Textduplikat | Centers of the Cancer Universe: A Half-Century of Progress Against Cancer |
http://cartcelljournal.com/ | Extern Textduplikat | Journal of CAR T-Cell Therapy |
http://cartcelljournal.com/about/ | Extern Textduplikat | About CAR T-cells |
http://cartcelljournal.com/faq/ | Extern Textduplikat | Frequently Asked Questions |
http://cartcelljournal.com/art... | Extern Textduplikat | Types of Articles |
http://cartcelljournal.com/for... | Extern Textduplikat | Submit a Manuscript |
/the_oncozine_brief_episodes/ | Subdomain Textduplikat | The Onco’Zine Brief |
/the_oncozine_brief_episodes/ | Subdomain Textduplikat | The Network |
/the-oncozine-brief-episodes/ | Subdomain Textduplikat | The Episodes |
https://www.patreon.com/theonc... | Neues Fenster Extern Subdomain Textduplikat | How to Support The Onco’Zine Brief |
/underwriting/ | Subdomain Textduplikat | Corporate Underwriting and Sponsorship |
/the-oncozine-dossier/ | Subdomain Textduplikat | The Onco’Zine Dossier |
/thalidomide-a-history/ | Subdomain Textduplikat | Thalidomide: A History |
/thalidomide-in-the-shadow-of-... | Subdomain Textduplikat | Thalidomide: In the Shadow of Death |
/controversy-the-involvement-o... | Subdomain Textduplikat | Controversy: The involvement of Ciba AG in the development of Thalidomide |
/thalidomides-secret-past-the-... | Subdomain Textduplikat | Thalidomide’s Secret Past: The Link with Nazi Germany |
/reversal-of-fortune-how-a-vil... | Subdomain Textduplikat | Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer |
/oncozine-dossier-50-years-aft... | Subdomain Textduplikat | Smoking and Health |
/new-surgeon-generals-report-p... | Subdomain Textduplikat | New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco |
/smoking-and-the-lost-legacy-o... | Subdomain Textduplikat | Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health |
/tobacco-control-in-the-united... | Subdomain Textduplikat | Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years |
http://.com/tobacco-companies-... | Extern Textduplikat | Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking |
/the-harmful-effects-of-smokin... | Subdomain Textduplikat | The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s |
/oncozine.com/oncology-hematol... | Subdomain Textduplikat | Drug Approvals 2017 – 2020 |
/oncology-hematology-drug-appr... | Subdomain Textduplikat | Oncology & Hematology – FDA Drug Approvals 2018 |
/oncology-hematology-fda-drug-... | Subdomain Textduplikat | Oncology & Hematology – FDA Drug Approvals 2019 |
/oncology-hematology-fda-drug-... | Subdomain Textduplikat | Oncology & Hematology – FDA Drug Approvals 2020 |
/category/articles/ | Subdomain Textduplikat | Articles |
/category/latest-articles/ | Subdomain Textduplikat | Latest Articles |
/category/expert-interviews/ | Subdomain Textduplikat | Expert Interviews |
/category/editorial-and-commen... | Subdomain Textduplikat | Editorials and Commentaries |
/category/eric-rosenthal-reports/ | Subdomain Textduplikat | Eric Rosenthal Reports |
/category/publications-peer-re... | Subdomain Textduplikat | Publications |
/category/news/ | Subdomain Textduplikat | News |
/category/business-economics/ | Subdomain Textduplikat | Business & Economics |
/category/clinical-development/ | Subdomain Textduplikat | Clinical Development |
/category/conference-coverage/ | Subdomain Textduplikat | Conference Coverage |
/the_oncozine_brief_episodes/ | Subdomain Textduplikat | The Onco’Zine Brief |
/the-oncozine-brief-episodes/ | Subdomain Textduplikat | The Episodes |
/the-oncozine-brief-national-a... | Subdomain Textduplikat | National Advertising |
http://www.oncozine.com/ | Neues Fenster Subdomain Textduplikat | Resources |
https://www.oncologydirectory.... | Neues Fenster Extern Subdomain Textduplikat | Membership |
https://www.oncologydirectory.... | Extern Subdomain Textduplikat | Agenda |
https://www.oncologydirectory.... | Neues Fenster Extern Subdomain Textduplikat | Join Today |
https://www.oncologydirectory.... | Neues Fenster Extern Subdomain Textduplikat | Video |
/job-openings/ | Subdomain Textduplikat | Careers |
/solutions-to-identify-patient... | Subdomain | A-TITLE Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials |
/solutions-to-identify-patient... | Subdomain Textduplikat | Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials A-TITLE Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials |
/author/kimberly_futch_001_bs-... | Subdomain | Kimberly Futch |
/crofelemer-reduces-diarrhea-i... | Subdomain | A-TITLE Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show |
/crofelemer-reduces-diarrhea-i... | Subdomain Textduplikat | Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show A-TITLE Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show |
/study-shows-new-co-star-recep... | Subdomain | A-TITLE Study Shows New Co-Star Receptor to be Promising in Cancer Treatment |
/study-shows-new-co-star-recep... | Subdomain Textduplikat | Study Shows New Co-Star Receptor to be Promising in Cancer Treatment A-TITLE Study Shows New Co-Star Receptor to be Promising in Cancer Treatment |
/the-concierge-catch-better-ac... | Subdomain | A-TITLE The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many |
/the-concierge-catch-better-ac... | Subdomain Textduplikat | The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many A-TITLE The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many |
/asco-2024-encouraging-dose-es... | Subdomain | A-TITLE ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011 |
/asco-2024-encouraging-dose-es... | Subdomain Textduplikat | ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011 A-TITLE ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011 |
/category/featured/ | Subdomain | FEATURED |
/solutions-to-identify-patient... | Subdomain Textduplikat | Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials A-TITLE Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials |
/author/kimberly_futch_001_bs-... | Subdomain Textduplikat | Kimberly Futch |
/crofelemer-reduces-diarrhea-i... | Subdomain Textduplikat | Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show A-TITLE Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show |
/author/okhuysen_pc-001/ | Subdomain | Pablo C. Okhuysen, M.D., FACP, FIDSA |
/the-concierge-catch-better-ac... | Subdomain Textduplikat | The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many A-TITLE The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many |
/author/john-rossheim_001a/ | Subdomain | John Rossheim |
/the-transformative-potential-... | Subdomain | The Transformative Potential of Exosome Research in Cancer Detection and Beyond A-TITLE The Transformative Potential of Exosome Research in Cancer Detection and Beyond |
/author/biological_d-hdhani_001/ | Subdomain | Harmeet Dhani, MD, MSc |
/a-global-view-of-oncology-inf... | Subdomain | A Global View of Oncology Informatics A-TITLE A Global View of Oncology Informatics |
/author/maria_dolores-mata-moy... | Subdomain | María Dolores de la Mata Moya |
/standardizing-immunophenotypi... | Subdomain | Standardizing Immunophenotyping Research Tools to Improve MDS and the Immune System A-TITLE Standardizing Immunophenotyping Research Tools to Improve MDS and the Immune System |
/author/leonardo_beretta_001-ad/ | Subdomain | Leonardo Beretta |
/experts-forecast-achieving-ca... | Subdomain | Experts Forecast: Achieving Cancer Health Equity A-TITLE Experts Forecast: Achieving Cancer Health Equity |
/author/neha_j_pancholi_001/ | Subdomain | Neha J. Pancholi, PhD |
/the-impact-of-dcisionrt-versu... | Subdomain | The Impact of DCISionRT Versus Clinicopathologic Factors Alone in Predicting Benefit of Radiation A-TITLE The Impact of DCISionRT Versus Clinicopathologic Factors Alone in Predicting Benefit of Radiation |
/author/amishi-bajaj-001/ | Subdomain | Amishi Bajaj, MD |
/category/news | Subdomain | NEWS |
/solutions-to-identify-patient... | Subdomain Textduplikat | Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials A-TITLE Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials |
/author/kimberly_futch_001_bs-... | Subdomain Textduplikat | Kimberly Futch |
/crofelemer-reduces-diarrhea-i... | Subdomain Textduplikat | Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show A-TITLE Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show |
/author/okhuysen_pc-001/ | Subdomain Textduplikat | Pablo C. Okhuysen, M.D., FACP, FIDSA |
/study-shows-new-co-star-recep... | Subdomain Textduplikat | Study Shows New Co-Star Receptor to be Promising in Cancer Treatment A-TITLE Study Shows New Co-Star Receptor to be Promising in Cancer Treatment |
/author/peter-hofland/ | Subdomain | Peter Hofland |
/the-concierge-catch-better-ac... | Subdomain Textduplikat | The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many A-TITLE The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many |
/author/john-rossheim_001a/ | Subdomain Textduplikat | John Rossheim |
/asco-2024-encouraging-dose-es... | Subdomain Textduplikat | ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011 A-TITLE ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011 |
/author/editorial_team/ | Subdomain | Editorial Team |
/asco-2024-adagrasib-shows-sta... | Subdomain | ASCO 2024: Adagrasib Shows Statistically Significant Improvement in PFS in KRASG12C-Mutated NSCLC A-TITLE ASCO 2024: Adagrasib Shows Statistically Significant Improvement in PFS in KRASG12C-Mutated NSCLC |
/author/editorial_team/ | Subdomain Textduplikat | Editorial Team |
/asco-2024-a-more-effective-tr... | Subdomain | ASCO 2024: A More Effective Treatment Combination for Hodgkin Lymphoma A-TITLE ASCO 2024: A More Effective Treatment Combination for Hodgkin Lymphoma |
/author/editorial_team/ | Subdomain Textduplikat | Editorial Team |
/asco-2024-asciminib-a-safer-m... | Subdomain | ASCO 2024: Asciminib – A Safer + More Effective Option for Newly Diagnosed Chronic... A-TITLE ASCO 2024: Asciminib – A Safer + More Effective Option for Newly Diagnosed Chronic Myeloid Leukemia |
/author/editorial_team/ | Subdomain Textduplikat | Editorial Team |
/asco-2024-durable-efficacy-of... | Subdomain | ASCO 2024: Durable Efficacy of Lorlatinib as a first-line choice in ALK-positive NSCLC n A-TITLE ASCO 2024: Durable Efficacy of Lorlatinib as a first-line choice in ALK-positive NSCLC n |
/author/editorial_team/ | Subdomain Textduplikat | Editorial Team |
/asco-2024-natalee-shows-riboc... | Subdomain | ASCO 2024: NATALEE shows Ribociclib Reduces Risk of Cancer Recurrence in Early Breast Cancer A-TITLE ASCO 2024: NATALEE shows Ribociclib Reduces Risk of Cancer Recurrence in Early Breast Cancer |
/author/editorial_team/ | Subdomain Textduplikat | Editorial Team |
/asco-2024-abbvie-to-showcases... | Subdomain | ASCO 2024: AbbVie to Showcases Robust Solid Tumor Pipeline with New Data from Its... A-TITLE ASCO 2024: AbbVie to Showcases Robust Solid Tumor Pipeline with New Data from Its ADC Platform |
/author/editorial_team/ | Subdomain Textduplikat | Editorial Team |
/strong-immunology-portfolio-h... | Subdomain | Strong Immunology Portfolio helps Offset losses of AbbVie’s Adalimumab A-TITLE Strong Immunology Portfolio helps Offset losses of AbbVie’s Adalimumab |
/author/editorial_team/ | Subdomain Textduplikat | Editorial Team |
/asco-2024-encouraging-dose-es... | Subdomain Textduplikat | ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011 A-TITLE ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011 |
/author/editorial_team/ | Subdomain Textduplikat | Editorial Team |
/asco-2024-adagrasib-shows-sta... | Subdomain Textduplikat | ASCO 2024: Adagrasib Shows Statistically Significant Improvement in PFS in KRASG12C-Mutated NSCLC A-TITLE ASCO 2024: Adagrasib Shows Statistically Significant Improvement in PFS in KRASG12C-Mutated NSCLC |
/author/editorial_team/ | Subdomain Textduplikat | Editorial Team |
/asco-2024-a-more-effective-tr... | Subdomain Textduplikat | ASCO 2024: A More Effective Treatment Combination for Hodgkin Lymphoma A-TITLE ASCO 2024: A More Effective Treatment Combination for Hodgkin Lymphoma |
/author/editorial_team/ | Subdomain Textduplikat | Editorial Team |
/asco-2024-asciminib-a-safer-m... | Subdomain Textduplikat | ASCO 2024: Asciminib – A Safer + More Effective Option for Newly Diagnosed Chronic... A-TITLE ASCO 2024: Asciminib – A Safer + More Effective Option for Newly Diagnosed Chronic Myeloid Leukemia |
/author/editorial_team/ | Subdomain Textduplikat | Editorial Team |
/asco-2024-durable-efficacy-of... | Subdomain Textduplikat | ASCO 2024: Durable Efficacy of Lorlatinib as a first-line choice in ALK-positive NSCLC n A-TITLE ASCO 2024: Durable Efficacy of Lorlatinib as a first-line choice in ALK-positive NSCLC n |
/author/editorial_team/ | Subdomain Textduplikat | Editorial Team |
/asco-2024-natalee-shows-riboc... | Subdomain Textduplikat | ASCO 2024: NATALEE shows Ribociclib Reduces Risk of Cancer Recurrence in Early Breast Cancer A-TITLE ASCO 2024: NATALEE shows Ribociclib Reduces Risk of Cancer Recurrence in Early Breast Cancer |
/author/editorial_team/ | Subdomain Textduplikat | Editorial Team |
/asco-2024-abbvie-to-showcases... | Subdomain Textduplikat | ASCO 2024: AbbVie to Showcases Robust Solid Tumor Pipeline with New Data from Its... A-TITLE ASCO 2024: AbbVie to Showcases Robust Solid Tumor Pipeline with New Data from Its ADC Platform |
/author/editorial_team/ | Subdomain Textduplikat | Editorial Team |
/asco-2024-bristol-myers-squib... | Subdomain | ASCO 2024: Bristol Myers Squibb to Present Results from 130 Studies A-TITLE ASCO 2024: Bristol Myers Squibb to Present Results from 130 Studies |
/author/editorial_team/ | Subdomain Textduplikat | Editorial Team |
/encouraging-conversation-acti... | Subdomain | Encouraging Conversation & Action on Sexual Health and Fertility for Patients Diagnosed with Cancer A-TITLE Encouraging Conversation & Action on Sexual Health and Fertility for Patients Diagnosed with Cancer |
/author/editorial_team/ | Subdomain Textduplikat | Editorial Team |
/increased-overall-survival-re... | Subdomain | Increased Overall Survival Reported for Combination of Durvalumab plus Chemotherapy A-TITLE Increased Overall Survival Reported for Combination of Durvalumab plus Chemotherapy |
/author/peter-hofland/ | Subdomain Textduplikat | Peter Hofland |
/study-shows-positive-results-... | Subdomain | Study Shows Positive Results in Treatment of Cervical High-Grade Squamous Intraepithelial Lesion A-TITLE Study Shows Positive Results in Treatment of Cervical High-Grade Squamous Intraepithelial Lesion |
/author/editorial_team/ | Subdomain Textduplikat | Editorial Team |
/immunotherapy-after-surgery-i... | Subdomain | Immunotherapy After Surgery Improves Survival in Patients with Kidney Cancer A-TITLE Immunotherapy After Surgery Improves Survival in Patients with Kidney Cancer |
/author/editorial_team/ | Subdomain Textduplikat | Editorial Team |
/category/editorial/ | Subdomain | EDITORIAL |
/a-global-view-of-oncology-inf... | Subdomain Textduplikat | A Global View of Oncology Informatics A-TITLE A Global View of Oncology Informatics |
/author/maria_dolores-mata-moy... | Subdomain Textduplikat | María Dolores de la Mata Moya |
/standardizing-immunophenotypi... | Subdomain Textduplikat | Standardizing Immunophenotyping Research Tools to Improve MDS and the Immune System A-TITLE Standardizing Immunophenotyping Research Tools to Improve MDS and the Immune System |
/author/leonardo_beretta_001-ad/ | Subdomain Textduplikat | Leonardo Beretta |
/experts-forecast-achieving-ca... | Subdomain Textduplikat | Experts Forecast: Achieving Cancer Health Equity A-TITLE Experts Forecast: Achieving Cancer Health Equity |
/author/neha_j_pancholi_001/ | Subdomain Textduplikat | Neha J. Pancholi, PhD |
/the-impact-of-dcisionrt-versu... | Subdomain Textduplikat | The Impact of DCISionRT Versus Clinicopathologic Factors Alone in Predicting Benefit of Radiation A-TITLE The Impact of DCISionRT Versus Clinicopathologic Factors Alone in Predicting Benefit of Radiation |
/author/amishi-bajaj-001/ | Subdomain Textduplikat | Amishi Bajaj, MD |
/forecast-2024-broadening-the-... | Subdomain | Forecast 2024: Broadening the Reach of Cancer Vaccines A-TITLE Forecast 2024: Broadening the Reach of Cancer Vaccines |
/author/neha_j_pancholi_001/ | Subdomain Textduplikat | Neha J. Pancholi, PhD |
/the-digital-frontier-5-ways-o... | Subdomain | The Digital Frontier: 5 Ways Oncology Informatics is Enhancing Cancer Care A-TITLE The Digital Frontier: 5 Ways Oncology Informatics is Enhancing Cancer Care |
/author/jesse-kaestner-001/ | Subdomain | Jesse Kaestner |
/category/eric-rosenthal-reports/ | Subdomain | ERIC ROSENTHAL REPORTS |
/remembering-emil-jay-freireic... | Subdomain | Remembering Emil “Jay” Freireich—the Man Who Made Vince DeVita a ‘Believer’ A-TITLE Remembering Emil “Jay” Freireich—the Man Who Made Vince DeVita a ‘Believer’ |
/author/erictrosenthal/ | Subdomain | Eric T. Rosenthal |
/why-were-top-hhs-officials-in... | Subdomain | Why Were Top HHS Officials? Interviews Thwarted by Their Press Offices? A-TITLE Why Were Top HHS Officials? Interviews Thwarted by Their Press Offices? |
/author/erictrosenthal/ | Subdomain Textduplikat | Eric T. Rosenthal |
/category/expert-interviews/ | Subdomain | EXPERT INTERVIEWS |
/jason-moore-phd-improving-the... | Subdomain | Jason Moore, PhD: Improving the Lives of Patients through Computing Technologies and Data Resources A-TITLE Jason Moore, PhD: Improving the Lives of Patients through Computing Technologies and Data Resources |
/author/editorial_team/ | Subdomain Textduplikat | Editorial Team |
/sonalasense-developing-a-safe... | Subdomain | SonALAsense: Developing a Safe and Effective Noninvasive Treatment for Cancer A-TITLE SonALAsense: Developing a Safe and Effective Noninvasive Treatment for Cancer |
/author/danielle_garcia/ | Subdomain | Danielle Garcia |
/be-the-match-improving-outcom... | Subdomain | Be The Match®: Improving Outcomes and Providing Hope to Patients in Need A-TITLE Be The Match®: Improving Outcomes and Providing Hope to Patients in Need |
/author/danielle_garcia/ | Subdomain Textduplikat | Danielle Garcia |
/the-oncozine-brief-episodes/ | Subdomain | IMG-ALT spot_img |
https://amzn.to/378W1I6 | Extern Textduplikat | IMG-ALT spot_img |
https://amzn.to/3Z0DFEU | Extern Textduplikat | IMG-ALT spot_img |
/solutions-to-identify-patient... | Subdomain Textduplikat | Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials A-TITLE Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials |
/author/kimberly_futch_001_bs-... | Subdomain Textduplikat | Kimberly Futch |
/crofelemer-reduces-diarrhea-i... | Subdomain Textduplikat | Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show A-TITLE Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show |
/author/okhuysen_pc-001/ | Subdomain Textduplikat | Pablo C. Okhuysen, M.D., FACP, FIDSA |
/study-shows-new-co-star-recep... | Subdomain Textduplikat | Study Shows New Co-Star Receptor to be Promising in Cancer Treatment A-TITLE Study Shows New Co-Star Receptor to be Promising in Cancer Treatment |
/author/peter-hofland/ | Subdomain Textduplikat | Peter Hofland |
/daiichi-sankyo-out-licenses-i... | Subdomain | Daiichi Sankyo Out-Licenses Investigational Agent DS-6051 to AnHeart Therapeutics A-TITLE Daiichi Sankyo Out-Licenses Investigational Agent DS-6051 to AnHeart Therapeutics |
/author/peter-hofland/ | Subdomain Textduplikat | Peter Hofland |
/how-meaningful-will-changes-b... | Subdomain | How Meaningful Will Changes Be to Ethical Guidelines Following Jose Baselga’s Fall? A-TITLE How Meaningful Will Changes Be to Ethical Guidelines Following Jose Baselga’s Fall? |
/author/erictrosenthal/ | Subdomain Textduplikat | Eric T. Rosenthal |
/reversal-of-fortune-how-a-vil... | Subdomain | Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’... A-TITLE Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer |
/author/peter-hofland/ | Subdomain Textduplikat | Peter Hofland |
/category/news/ | Subdomain | News2935 |
/category/conference-coverage/ | Subdomain | Conference Coverage507 |
/category/research-and-develop... | Subdomain | Research & Development364 |
/category/cancer-risk/ | Subdomain | Cancer Risk304 |
/category/clinical-trial-updates/ | Subdomain | Clinical Trial Updates277 |
/category/clinical-development/ | Subdomain | Clinical development271 |
/category/business-economics/ | Subdomain | Business & Economics197 |
/category/regulatory-updates/ | Subdomain | Regulatory Updates120 |
/category/op-ed-opinion/ | Subdomain | Op-Ed | Opinion112 |
/category/must-read-articles/ | Subdomain | Must Read Articles110 |
https://www.oncozine.com/ | Subdomain | IMG-ALT Onco\'Zine, The International Oncology Network |
https://www.facebook.com/oncoz... | Neues Fenster Extern Subdomain Textduplikat | A-TITLE Facebook |
https://www.linkedin.com/showc... | Neues Fenster Extern Subdomain Textduplikat | A-TITLE Linkedin |
https://soundcloud.com/hofrey | Neues Fenster Extern Textduplikat | A-TITLE Soundcloud |
https://twitter.com/OncoZine | Neues Fenster Extern Textduplikat | A-TITLE Twitter |
https://vimeo.com/channels/877242 | Neues Fenster Extern Textduplikat | A-TITLE Vimeo |
https://www.youtube.com/channe... | Neues Fenster Extern Subdomain Textduplikat | A-TITLE Youtube |
https://www.xing.com/communiti... | Neues Fenster Extern Subdomain Textduplikat | A-TITLE Xing |
https://www.oncozine.com/ | Subdomain Textduplikat | Home |
/advertisement-sponsorship-opt... | Subdomain Textduplikat | Advertisement & Sponsorship Options |
https://lp.constantcontactpage... | Extern Subdomain Textduplikat | Download Our Media Kit |
/continued-medical-education-cme/ | Subdomain Textduplikat | Changing Physician Behavior |
/cancer-information-by-disease/ | Subdomain Textduplikat | Cancer A – Z |
http://www.oncozine.com/ | Subdomain Textduplikat | Drug Developmemt Technologies |
/a-novel-technology-based-on-s... | Subdomain Textduplikat | A Novel Technology based on Somatic Hypermutation (SHM) |
/about-oncozine/advisory-board-3/ | Subdomain Textduplikat | Editorial Advisory Board |
/join-our-editorial-advisory-b... | Subdomain Textduplikat | Join Our Editorial Advisory Board |
/contact-us/ | Subdomain Textduplikat | Contact Us |
/terms-and-conditions/ | Subdomain Textduplikat | Terms and Conditions |
/sabcs-and-ash-2023/ | Subdomain Textduplikat | SABCS and ASH 2023 |
http://www.adcreview.com/ | Extern Subdomain Textduplikat | ADC Review | J. Antibody-drug Conjugates |
https://www.adcreview.com/reso... | Extern Subdomain Textduplikat | Resources for For Clinicians |
https://www.adcreview.com/adc-... | Extern Subdomain Textduplikat | Drug Map (ADC) |
https://www.adcreview.com/cate... | Extern Subdomain Textduplikat | Peer Review Articles |
https://www.adcreview.com/the-... | Extern Subdomain Textduplikat | The Review |
/changing-strategies-in-the-wa... | Subdomain Textduplikat | Changing Strategies in the War on Cancer |
/changing-strategies-in-the-wa... | Subdomain Textduplikat | Changing Strategies in the War on Cancer – Episode 1 |
/changing-strategies-in-the-wa... | Subdomain Textduplikat | Changing Strategies in the War on Cancer – Episode 2 |
/changing-strategies-in-the-wa... | Subdomain Textduplikat | Changing Strategies in the War on Cancer – Episode 3 |
/centers-of-the-cancer-univers... | Subdomain Textduplikat | Centers of the Cancer Universe: A Half-Century of Progress Against Cancer |
http://cartcelljournal.com/ | Extern Textduplikat | Journal of CAR T-Cell Therapy |
http://cartcelljournal.com/about/ | Extern Textduplikat | About CAR T-cells |
http://cartcelljournal.com/faq/ | Extern Textduplikat | Frequently Asked Questions |
http://cartcelljournal.com/art... | Extern Textduplikat | Types of Articles |
http://cartcelljournal.com/for... | Extern Textduplikat | Submit a Manuscript |
/the_oncozine_brief_episodes/ | Subdomain Textduplikat | The Onco’Zine Brief |
/the_oncozine_brief_episodes/ | Subdomain Textduplikat | The Network |
/the-oncozine-brief-episodes/ | Subdomain Textduplikat | The Episodes |
https://www.patreon.com/theonc... | Neues Fenster Extern Subdomain Textduplikat | How to Support The Onco’Zine Brief |
/underwriting/ | Subdomain Textduplikat | Corporate Underwriting and Sponsorship |
/the-oncozine-dossier/ | Subdomain Textduplikat | The Onco’Zine Dossier |
/thalidomide-a-history/ | Subdomain Textduplikat | Thalidomide: A History |
/thalidomide-in-the-shadow-of-... | Subdomain Textduplikat | Thalidomide: In the Shadow of Death |
/controversy-the-involvement-o... | Subdomain Textduplikat | Controversy: The involvement of Ciba AG in the development of Thalidomide |
/thalidomides-secret-past-the-... | Subdomain Textduplikat | Thalidomide’s Secret Past: The Link with Nazi Germany |
/reversal-of-fortune-how-a-vil... | Subdomain Textduplikat | Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer |
/oncozine-dossier-50-years-aft... | Subdomain Textduplikat | Smoking and Health |
/new-surgeon-generals-report-p... | Subdomain Textduplikat | New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco |
/smoking-and-the-lost-legacy-o... | Subdomain Textduplikat | Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health |
/tobacco-control-in-the-united... | Subdomain Textduplikat | Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years |
http://.com/tobacco-companies-... | Extern Textduplikat | Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking |
/the-harmful-effects-of-smokin... | Subdomain Textduplikat | The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s |
/oncozine.com/oncology-hematol... | Subdomain Textduplikat | Drug Approvals 2017 – 2020 |
/oncology-hematology-drug-appr... | Subdomain Textduplikat | Oncology & Hematology – FDA Drug Approvals 2018 |
/oncology-hematology-fda-drug-... | Subdomain Textduplikat | Oncology & Hematology – FDA Drug Approvals 2019 |
/oncology-hematology-fda-drug-... | Subdomain Textduplikat | Oncology & Hematology – FDA Drug Approvals 2020 |
/category/articles/ | Subdomain Textduplikat | Articles |
/category/latest-articles/ | Subdomain Textduplikat | Latest Articles |
/category/expert-interviews/ | Subdomain Textduplikat | Expert Interviews |
/category/editorial-and-commen... | Subdomain Textduplikat | Editorials and Commentaries |
/category/eric-rosenthal-reports/ | Subdomain Textduplikat | Eric Rosenthal Reports |
/category/publications-peer-re... | Subdomain Textduplikat | Publications |
/category/news/ | Subdomain Textduplikat | News |
/category/business-economics/ | Subdomain Textduplikat | Business & Economics |
/category/clinical-development/ | Subdomain Textduplikat | Clinical Development |
/category/conference-coverage/ | Subdomain Textduplikat | Conference Coverage |
/the_oncozine_brief_episodes/ | Subdomain Textduplikat | The Onco’Zine Brief |
/the-oncozine-brief-episodes/ | Subdomain Textduplikat | The Episodes |
/the-oncozine-brief-national-a... | Subdomain Textduplikat | National Advertising |
http://www.oncozine.com/ | Neues Fenster Subdomain Textduplikat | Resources |
https://www.oncologydirectory.... | Neues Fenster Extern Subdomain Textduplikat | Membership |
https://www.oncologydirectory.... | Extern Subdomain Textduplikat | Agenda |
https://www.oncologydirectory.... | Neues Fenster Extern Subdomain Textduplikat | Join Today |
https://www.oncologydirectory.... | Neues Fenster Extern Subdomain Textduplikat | Video |
/job-openings/ | Subdomain Textduplikat | Careers |
https://lp.constantcontactpage... | Neues Fenster Extern Subdomain | Kein Text |
Name | Wert |
---|---|
server | nginx |
date | Sun, 14 Jul 2024 05:25:10 GMT |
content-type | text/html; charset=UTF-8 |
vary | Accept-Encoding |
x-cache-enabled | True |
link | <https://www.oncozine.com/wp-json/>; rel="https://api.w.org/", <https://www.oncozine.com/wp-json/wp/v2/pages/6893>; rel="alternate"; type="application/json", <https://www.oncozine.com/>; rel=shortlink |
x-httpd | 1 |
x-cdn-c | all |
content-encoding | gzip |
x-sg-cdn | 1 |
x-proxy-cache | HIT |
host-header | 8441280b0c35cbc1147f8ba998a563a7 |
statuscode | 200 |
http_version | HTTP/2 |
# START WPFORMS BLOCK # --------------------------- User-agent: * Disallow: /wp-content/uploads/wpforms/ # --------------------------- # END WPFORMS BLOCK # START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://www.oncozine.com/sitemap_index.xml # --------------------------- # END YOAST BLOCK
Folgende Keywords wurden erkannt. Überprüfe die Optimierung dieser Keywords für Deine Seite.
Keyword | Ergebnis | Prüfen |
---|---|---|
Onco | 95% | Check |
Onco Zine | 94% | Check |
Zine | 91% | Check |
Oncology | 80% | Check |
Oncology Network | 78% | Check |
Network | 76% | Check |
Onco Zine Brief | 75% | Check |
Oncology Hematology | 69% | Check |
News Network | 69% | Check |
Hematology News Network | 65% | Check |
News | 61% | Check |
Oncology Informatics | 61% | Check |
Oncology Hematology FDA | 57% | Check |
Cancer | 56% | Check |
Hematology | 56% | Check |
Cancer Patients | 55% | Check |
Patients | 54% | Check |
inform | 54% | Check |
Oncology Hematology FDA Drug | 52% | Check |
Better | 51% | Check |
Cancer Treatment | 49% | Check |
Breast Cancer | 49% | Check |
Cancer Health | 49% | Check |
Kidney Cancer | 49% | Check |
Cancer Episode | 47% | Check |
Bitte wähle eine der Optionen.
Kontakt-Optionen
Schreibe eine Email an [email protected]
Rufe uns an unter +49 911 23756261
Mo-Fr
9 bis 17 Uhr
Weitere Hilfe findest Du im Erste Schritte Guide,
oder besuche unsere FAQ, unser Wiki oder unseren Blog.
Bitte wähle eine der Optionen.
Wir haben Deine Nachricht erhalten und werden sie sobald wie möglich bearbeiten.
Wir verwenden Cookies, damit unsere Website funktioniert und auch für Analyse- und Werbezwecke. Du kannst optionale Cookies selbstverständlich auch deaktivieren, siehe die folgenden Links für weitere Informationen.
Diese Cookies werden für grundlegende Websitefunktionen benötigt.
Damit wir besser verstehen, wie Besucher unsere Website nutzen.
Damit wir für Dich passgenaue Angebote bereitstellen können.
(Nice to have)